Frontiers Winter 2010
Role Change: Providing an opportunity for leaders to experience life with cancer
Cancer still kills more than 560,000 Americans every year. Progress against this deadly disease is linked hand-in-glove with funding for cancer research. Higher funding levels are needed, and that requires the support of the public and of state and federal legislative leaders.
One of my initiatives as president of the American Association of Cancer Institutes is to promote an advocacy program called Project Cancer Education. Developed here at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James), this two-hour curriculum offers legislative and opinion leaders an opportunity to experience life as a cancer patient or caregiver. They also gain a greater understanding of translational research, the relationship between research and patient care, and the need for clinical trials access and additional cancer research funding. For information about Project Cancer Education, write to us at Frontiers@osumc.edu.
I am pleased to report that the OSUCCC-James leukemia program achieved distinction this summer when the National Cancer Institute (NCI) awarded a five-year, $11.5 million Specialized Program of Research Excellence (SPORE) grant to principal investigator John C. Byrd, MD, and co-principal investigators Clara D. Bloomfield, MD, and Guido Marcucci, MD. This is only the second SPORE grant to be directed at leukemia research. This issue of Frontiers as information about the outstanding research this grant supports.
This issue’s cover story describes the work of Maura Gillison, MD, PhD, an OSUCCC – James researcher who has done much to establish the link between oral human papillomavirus and oropharyngeal cancer.
Finally, travel to a Borneo rainforest, then back to The Ohio State University laboratory of A. Douglas Kinghorn, PhD, DSc, to follow the discovery of a natural product that shows unique antileukemic activity.
We hope you enjoy reading this issue of Frontiers as much as we enjoy presenting the research it describes.